ReShape Lifesciences Inc (RSLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
37
About the Report
About the Report
Summary
ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic diseases; and ReShape Balloon System, which is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients and obesity-related comorbid conditions. ReShape's vBloc therapy is a rechargeable neuroregulator that is implanted subcutaneously and attached to the vagal nerve. The company's product vBloc is a minimally invasive therapy that does not alter patient's anatomy. ReShape is headquartered in San Clemente, California, the US.
ReShape Lifesciences Inc (RSLS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
ReShape Lifesciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Reshape Medical Raises USD38 Million in Series D Financing 11
Reshape Medical Raises Additional USD3.5 Million in Venture Financing 13
Reshape Medical Raises Additional USD1.25 Million in Venture Financing 14
Equity Offering 15
ReShape Lifesciences Plans to Raise USD15 Million in Public Offering of Shares 15
ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 16
EnteroMedics Raises USD20 Million in Public Offering of Units 18
Debt Offering 20
EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 20
EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 21
EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 22
Acquisition 23
EnteroMedics Acquires BarioSurg 23
ReShape Lifesciences Inc-Key Competitors 24
ReShape Lifesciences Inc-Key Employees 25
ReShape Lifesciences Inc-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 14, 2018: Reshape lifesciences reports second quarter 2018 financial results 27
May 14, 2018: ReShape Lifesciences Announces Record Revenue for First Quarter 2018 28
Apr 02, 2018: ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results 29
Feb 01, 2018: ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue 30
Aug 08, 2017: EnteroMedics Announces Second Quarter 2017 Financial Results 31
May 16, 2017: EnteroMedics Announces First Quarter 2017 Financial Results 32
Mar 07, 2017: EnteroMedics Reports Fourth Quarter 2016 Financial Results 33
Product News 35
Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity 35
Jan 05, 2017: EnteroMedics Announces vBloc Neurometabolic Therapy Now Available at MedStar Health and Roper St. Francis 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ReShape Lifesciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
ReShape Lifesciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Reshape Medical Raises USD38 Million in Series D Financing 11
Reshape Medical Raises Additional USD3.5 Million in Venture Financing 13
Reshape Medical Raises Additional USD1.25 Million in Venture Financing 14
ReShape Lifesciences Plans to Raise USD15 Million in Public Offering of Shares 15
ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 16
EnteroMedics Raises USD20 Million in Public Offering of Units 18
EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 20
EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 21
EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 22
EnteroMedics Acquires BarioSurg 23
ReShape Lifesciences Inc, Key Competitors 24
ReShape Lifesciences Inc, Key Employees 25
ReShape Lifesciences Inc, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.